CSANZ Logo
CSANZ Logo
Welcome to the official website of the


CSANZ Logo
CSANZ Logo
Cardiac Society of Australia and New Zealand
CSANZ Logo


CSANZ Logo


CSANZ Logo

contact
links
want to join?
register
search the CSANZ website
search the CSANZ website
     







search the CSANZ website













CSANZ Directory

CSANZ Member Directory

CSANZ Guidelines

Practice Guidelines

Training and Competence

Meetings

What's On and Where

ASM Abstracts Online

News and Views

Newsletter - On the Pulse

Newsletter - CNWG

In the News

Affiliate News
Career Opportunities

Affiliate Member Area

Affiliate Calendar

Affiliate Discussion

Scholarships/ Fellowships

Working Groups


ASM Abstracts

INHIBITION OF THE HUMAN CARDIAC POTASSIUM CHANNEL, HERG, BY SOTALOL HYDROCHLORIDE.

B D Walker, H Tie, C B Singleton, J A Bursill, K R Wyse, M R Qiu, S M Valenzuela, S N Breit, T J Campbell.

Department of Medicine, Victor Chang Cardiac Research Institute and Centre for Immunology, St Vincent's Hospital, Darlinghurst, NSW

Background:  Class III antiarrhythmic drugs and non-cardiac drugs which cause QT prolongation (eg. cisapride, terfenadine) commonly inhibit the rapidly activating delayed rectifier potassium channel (Ikr), which is encoded by the human ether-a-go-go-related gene (HERG).  There is surprisingly limited information regarding the effects of sotalol on the biophysics of Ikr, or HERG currents at a single cell level.

Methods and results: Whole cell voltage-clamp technology was used to study the current produced in Chinese hamster ovary (CHO-K1) cells stable transfected with HERG. D,L-solatol is a relatively weak inhibitor of HERG tail currents (IC50 198 mM, 95%CI 122 - 321 mM), in contrast to the sotalol analog, E-4031, which inhibited the channel with 1000-fold greater potency (IC50 134 nM, 95%CI 113 - 160 nM). Inhibition by D,L-solatol 300 mM exhibited reverse use-dependence (22 + 6% block after 40 pulses at 0.5 Hz vs 70 + 5% block at 0.1 Hz, p < 0.05), which has not previously been described at the single cell level.  Channel block occurred both in the resting state and after channel opening (tblock = 4 min, 0.1 Hz stimulation), with washout also occurring slowly (~ 80% complete at 30 min). The time course of channel deactivation was significantly prolonged in the presence of D,L-solatol (tfast 677 + 64 ms in control, 1328 + 160 ms sotalol, p < 0.05) suggestive of unbinding from open channels during cell repolarization. D,L-solatol had no effect on the time course or the voltage dependence of channel activation or inactivation.

Conclusions: D,L-solatol weakly inhibits HERG (human therapeutic plasma concentration:  2 - 6 mM), suggesting that the drug may have a greater effect on another repolarizing current.  Channel blockade develops slowly with greatest affinity for a closed (resting) state.

[ Back to 47th ASM Abstract Index ]


Med-E-Serv